Altre lingue Mustang Bio, Inc.

Azioni

MBIO

US62818Q2030

Tempo reale stimato Cboe BZX Altri mercati azionari 21:14:53 27/06/2024			Variaz. 5gg	Var. 1 gen.
0,454 ^USD	+2,30%		-16,86%	-65,48%

21/06	Aggiornamento settoriale: i titoli del settore sanitario sono fermi nel premercato di venerdì	MT
20/06	Mustang Bio raccoglierà 2,5 milioni di dollari dall'offerta di azioni	MT

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Sector Update: Health Care Stocks Steady Premarket Friday	21/06
Mustang Bio to Raise $2.5 Million From Share Offering	20/06
Mustang Bio Expects $2.5 Million Gross Proceeds From Registered Direct Offering, Private Placement	20/06
Mustang Bio Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules	20/06
Mustang Bio Announces Favorable Efficacy and Safety Data from Complete Waldenstrom Macroglobulinemia Cohort of phase Clinical Trial of MB-106, CD20-Targeted Autologous CAR-T Therapy	18/06
US Equities Markets Rise; Tech Stocks Boost S&P 500, Nasdaq to Records	17/06
Sector Update: Health Care Stocks Retreat Late Afternoon	17/06
Top Midday Gainers	17/06
Sector Update: Health Care Stocks Ease in Afternoon Trading	17/06
Mustang Bio Shares Rise After Company Says CAR-T Therapy Indicates 90% Response Rate in WM Blood Cancer Trial	17/06
Mustang Bio Announces Favorable Efficacy and Safety Data from Complete Waldenstrom Macroglobulinemia Cohort of Phase 1/2 Clinical Trial of MB-106, CD20-Targeted Autologous CAR-T Therapy	17/06
Mustang Bio, Inc. Announces Favorable Efficacy and Safety Data from Complete Waldenstrom Macroglobulinemia Cohort of Phase 1/2 Clinical Trial of Mb-106, Cd20-Targeted Autologous Car-T Therapy	17/06
Mustang Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	15/05
Mustang Bio Announces Closing of $4 Million Public Offering	02/05
Mustang Bio, Inc. announced that it has received $3.3 million in funding	02/05
Mustang Bio Prices Public Offering of 16.9 Million Shares, Accompanying Warrants	30/04
Mustang Bio Announces Pricing of $4 Million Public Offering	30/04
Mustang Bio : Results of Operations and Financial Condition - Form 8-K	29/04
Mustang Bio, Inc. announced that it expects to receive $3.3 million in funding	29/04
North American Morning Briefing : Stock Futures Rise Despite Middle East Tensions	15/04

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Mustang Bio, Inc.

Azioni

MBIO

US62818Q2030

Altre lingue

Filtri